Related Experiment Videos
Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions.
J G Howell1, G B Zibari, M F Brown
1Department of Surgery, Louisiana State University Medical Center, Shreveport 71130, USA.
Transplantation
|February 12, 2000
Summary
Mechanical and pharmacological preconditioning significantly reduce leukocyte-endothelial cell interactions and liver damage from ischemia/reperfusion (I/R) injury, offering hepatic protection.
Area of Science:
- Hepatology
- Immunology
- Cardiovascular Research
Background:
- Ischemic preconditioning (IPC) protects tissues from ischemia/reperfusion (I/R) injury.
- Adenosine plays a key role by reducing leukocyte-endothelial cell adhesion.
- Dipyridamole enhances adenosine bioavailability.
Purpose of the Study:
- To evaluate the effects of mechanical preconditioning (MPC) and pharmacological preconditioning (PPC) on leukocyte-endothelial cell interactions in hepatic I/R injury.
Main Methods:
- C57BL6 mice underwent 30 minutes of liver ischemia followed by varying reperfusion times.
- Groups included sham laparotomy, I/R, MPC, and PPC (dipyridamole).
- Intravital microscopy assessed leukocyte-endothelial cell adhesion; blood tests measured liver function and leukocyte counts.
Main Results:
- Both PPC and MPC significantly decreased leukocyte rolling at 30 minutes and 5 hours post-reperfusion compared to I/R.
- Leukocyte saltation was reduced in PPC and MPC groups at 2, 5, and 12 hours.
- Aspartate aminotransferase levels were significantly lower in preconditioned groups at 5 hours, but white blood cell counts were not significantly affected.
Conclusions:
- Preconditioning effectively reduces leukocyte-endothelial cell interactions.
- Both IPC and PPC offer a degree of hepatic protection against I/R injury, evidenced by reduced liver damage markers.